BCYC
Bicycle Therapeutics·NASDAQ
--
--(--)
--
--(--)
4.27 / 10
Netural
Fund‑flow metrics are strong (7.39/10), with overall inflow positive despite mixed segment trends. Analyst sentiment leans bullish (25% Strong Buy, 50% Buy), yet historical win rates are low, indicating limited confidence. The juxtaposition yields a cautiously optimistic outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
25%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-18
InstitutionNeedham
Times predicted3
Historical Win Rate33.3%
What is the analyst consensus for BCYC?
- BCYC holds a Bearish analyst rating, with 50% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.27/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
